E-ISSN 2231-3206 | ISSN 2320-4672

2017, Vol:6,Issue:5

Research Articles
  • Indi J Medic Science and P Health.2017; Volume:6(5):893-895 doi : 10.5455/ijmsph.2017.1165616122016
  • Study of serum malonyldialdehyde (marker of lipid peroxidation) and paraoxonase-1 in chronic obstructive pulmonary disease patients with alterations in their lipid profile in Muzaffarnagar region
  • Shikha Rawat, Manisha Arora, Imran Mustafa, Sameer Anand, Sudeep Kumar, Roshan Kumar Mahat,Manju Sharma

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a term for a group of diseases that affects lung.
Objective: Objective of our study was to evaluate paraoxonase-1 (PON1) activity, malonyldialdehyde (MDA) and lipid profile in COPD patients and healthy control.
Materials and Methods: Serum MDA and PON1 level were measured by Kei Satoh and arylesterase method, where lipid profile was determined by biochemistry fully autoanalyzer (CPC TurboChem 100).
Results: The mean level of (marker of oxidative stress malonyldialdehyde) MDA was profoundly higher in cases (P < 0.0001) as compared to control group. The antioxidant enzyme PON1 were lower (P < 0.0001) in cases than control. The mean levels of total cholesterol, triglyceride, low-density lipoprotein (LDL), very LDL were significantly higher in cases as compared to control group. The mean level of high-density lipoprotein was lower in COPD patients as compared to control group. Conclusion: Our results concluded that the reduction in PON1 activity could reflect oxidative changes of enzyme free cysteine residues.